Literature DB >> 7594340

Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.

T Fukuda1, T Arakawa, Y Shimizu, K Ohtani, K Higuchi, K Kobayashi.   

Abstract

Lansoprazole, a proton pump inhibitor, has been reported to inhibit ethanol-induced injury in rats. However, the mechanism of the protective effect is not known. This study was carried out to investigate the role of prostaglandin (PG) in the protective effect of lansoprazole. Male Wistar rats were given either 30 mg/kg of lansoprazole or vehicle alone intragastrically 30 min before administration of ethanol. They were killed to measure the gross mucosal lesions in the stomach as the ulcer index. In another experiment, 5 mg/kg of indomethacin was injected 30 min before administration of lansoprazole. The effects of 16,16-dimethyl PGE2 (dmPGE2) on ethanol-induced injury over time were compared with lansoprazole. PGE2 synthesis in gastric mucosa after administration of lansoprazole was measured by radioimmunoassay. Lansoprazole reduced gastric mucosal injury by lansoprazole. DmPGE2 significantly reduced gastric mucosal injury from 5 min after exposure to ethanol. Lansoprazole did not affect PGE2 synthesis in the gastric mucosa. These results suggest that PG may not be involved in the protective effect of lansoprazole.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594340     DOI: 10.1097/00004836-199506002-00003

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

Review 1.  Present status and strategy of NSAIDs-induced small bowel injury.

Authors:  Kazuhide Higuchi; Eiji Umegaki; Toshio Watanabe; Yukiko Yoda; Eijiro Morita; Mitsuyuki Murano; Satoshi Tokioka; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

2.  Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Gianfranco Natale; Valter Lubrano; Cristina Vassalle; Luca Antonioli; Gloria Lazzeri; Mario Del Tacca
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.

Authors:  M Fornai; G Natale; R Colucci; M Tuccori; G Carazzina; L Antonioli; S Baldi; V Lubrano; A Abramo; C Blandizzi; M Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-04       Impact factor: 3.000

4.  Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.

Authors:  C Blandizzi; G Natale; G Gherardi; G Lazzeri; C Marveggio; R Colucci; D Carignani; M Del Tacca
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 5.  Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.

Authors:  Halis Suleyman; Abdulmecit Albayrak; Mehmet Bilici; Elif Cadirci; Zekai Halici
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

6.  Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells.

Authors:  Kanho Rai; Hirofumi Matsui; Tsuyoshi Kaneko; Yumiko Nagano; Osamu Shimokawa; Jumpei Udo; Aki Hirayama; Ichinosuke Hyodo; Hiroko P Indo; Hideyuki J Majima
Journal:  J Clin Biochem Nutr       Date:  2011-06-17       Impact factor: 3.114

7.  Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.

Authors:  Kazuhide Higuchi; Yukiko Yoda; Kikuko Amagase; Shinichi Kato; Satoshi Tokioka; Mitsuyuki Murano; Koji Takeuchi; Eiji Umegaki
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

8.  Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico Approach.

Authors:  Melina Luzzi Zarricueta; Felipe Leonardo Fagundes; Quélita Cristina Pereira; Simone Queiroz Pantaleão; Raquel de Cássia Dos Santos
Journal:  Pharmaceutics       Date:  2022-03-04       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.